Biohit Oyj comments on the claims presented in public by a member of Biohit board of directors, Mr. Liu Feng

Read more

A study from Italy confirms: Low levels of G-17 biomarker of the GastroPanel® test predict the risk of esophagitis and esophageal reflux disease

Read more

European Union and Business Finland provide Biohit Oyj with a total of EUR 900,000 in financing for product development

Read more